E. Erdei and S. M. Torres, A new understanding in the epidemiology of melanoma, Expert Review of Anticancer Therapy, vol.10, issue.11, pp.1811-1823, 2010.
DOI : 10.1586/era.10.170

F. Erdmann, J. Lortet-tieulent, J. Schuz, H. Zeeb, R. Greinert et al., International trends in the incidence of malignant melanoma 1953-2008-are recent generations at higher or lower risk?, International Journal of Cancer, vol.13, issue.2, pp.385-400, 2013.
DOI : 10.1002/ijc.27616

R. Besch, M. L. Hartman, and M. Czyz, [4] For some recent reviews on this topic see Anti-apoptotic proteins on guard of melanoma cell survival and references cited therein. [5] For some recent reviews on this topic see also: Plötz, M.; Eberle, J. BH3-only proteins -possible proapoptotic triggers for melanoma therapy and references cited therein. [6] For a recent review on this topic see: Mohana-Kumaran, Selective induction of cell death in melanoma cell lines through targeting of Mcl-1 and A1 Haass, N. K. Targeting the intrinsic apoptosis pathway as a strategy for melanoma therapy, pp.1-11, 2012.

D. D. Vo, F. Gautier, P. Juin, and R. Grée, Structure???activity relationship of selected polyphenol derivatives as inhibitors of Bax/Bcl-xL interaction, European Journal of Medicinal Chemistry, vol.51, pp.286-293, 2012.
DOI : 10.1016/j.ejmech.2012.02.036
URL : https://hal.archives-ouvertes.fr/hal-00841554

D. D. Vo, F. Gautier, S. Barillé-nion, and P. Juin, Levoin N.; Grée R. Synthesis of new mixed phenol/heterocyclic derivatives and studies of their activity as inhibitors of Bax/Bcl-xL interaction, Tetrahedron, vol.709, pp.301-311, 2014.

D. D. Vo, F. Gautier, S. Barillé-nion, P. Juin, and N. Levoin, Grée, R. Design, synthesis and biological evaluation of new inhibitors of Bax/Bcl-xL interaction in cancer cells, Bioorg. Med. Chem. Lett, vol.2410, pp.1758-1761, 2014.

N. Levoin, D. D. Vo, F. Gautier, S. Barillé-nion, P. Juin et al., A combination of in silico and SAR studies to identify binding hot spots of Bcl-xL inhibitors, Bioorganic & Medicinal Chemistry, vol.23, issue.8, pp.1747-1757, 2015.
DOI : 10.1016/j.bmc.2015.02.060
URL : https://hal.archives-ouvertes.fr/hal-01133213

P. Cartron, O. Geneste, R. Grée, F. M. Vallette, and P. Juin, The small organic compound HA14-1 sensitizes human glioblastoma cells to induction of cell death through inhibition of Bcl-2, Cancer Res, vol.6612, pp.2757-2764, 2006.
URL : https://hal.archives-ouvertes.fr/hal-00322859

L. Oliver, B. Mahé, R. Grée, F. M. Vallette, P. Juin et al., HA14-1, a small molecule inhibitor of Bcl-2, bypasses chemoresistance in leukaemia cells, Leukemia Research, vol.31, issue.6, pp.859-863, 2007.
DOI : 10.1016/j.leukres.2006.11.010
URL : https://hal.archives-ouvertes.fr/hal-00323090

M. G. Jasiulionis, R. L. De-ameida, D. P. Rivelli, R. C. Albuquerque, T. F. De-oliveira et al., Proteasome inhibition and ROS generation by 4-nerolidylcatechol induces melanoma cell death, Pig Cell Melanoma J. A, vol.2514, pp.354-369, 2012.

A. Alcacer, J. Alcacer-coronado, J. Estrela, and J. M. , Glucocorticoid receptor knockdown decreases the antioxidant protection of B16 melanoma cells: an endocrine system-related mechanism that compromises metastatic cell resistance to vascular endotheliuminduced tumor cytotoxicity, Plos One, vol.2014, issue.9, p.96466

J. Boustie, Metabolites from the lichen Ochrolechia parella growing under two different heliotropic conditions, J. Nat. Prod, vol.70, pp.316-318, 2007.

F. Ismed, . Lohézic-le, F. Dévehat, O. Delalande, S. Sinbandhit et al., Lobarin from the Sumatran lichen, Stereocaulon halei, Fitoterapia, vol.83, issue.8, pp.1693-1698, 2012.
DOI : 10.1016/j.fitote.2012.09.025
URL : https://hal.archives-ouvertes.fr/hal-00813194

L. Coiffard, Lichenic extracts and metabolites as UV filters, J. Photochem . Photobiol. B, vol.120, pp.17-28, 2013.
URL : https://hal.archives-ouvertes.fr/hal-00865297

C. Bézivin, S. Tomasi, F. Lohézic-le-dévéhat, and J. Boustie, Cytotoxic activity of some lichen extracts on murine and human cancer cell lines, Phytomedicine, vol.10, issue.6-7, pp.499-503, 2003.
DOI : 10.1078/094471103322331458